GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Celemics Inc (XKRX:331920) » Definitions » Total Current Assets

Celemics (XKRX:331920) Total Current Assets : ₩11,264 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Celemics Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Celemics's total current assets for the quarter that ended in Sep. 2024 was ₩11,264 Mil.


Celemics Total Current Assets Historical Data

The historical data trend for Celemics's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celemics Total Current Assets Chart

Celemics Annual Data
Trend Dec15 Dec16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Current Assets
Get a 7-Day Free Trial 4,506.26 28,310.77 22,967.93 15,612.83 12,708.08

Celemics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,005.60 12,708.08 12,491.56 12,432.31 11,264.25

Celemics Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Celemics's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Celemics's Total Current Assets for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Celemics  (XKRX:331920) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Celemics's Liquidation Value for the quarter that ended in Sep. 2024 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=8249.055-1735.22+0.75 * 389.302+0.5 * 1281.922
=7,447

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Celemics Total Current Assets Related Terms

Thank you for viewing the detailed overview of Celemics's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Celemics Business Description

Traded in Other Exchanges
N/A
Address
131 Gasandigital 1-ro, Geumcheon-gu, 19-20 Floor, Building A, BYC Highcity, Seoul, KOR, 08506
Celemics Inc is a manufacturer of Next Generation Sequencing test kit. It offers, develops and manufactures proprietary DNA and genetic sequencing test kits and panels. Its products include Targeted Sequencing Kit, NGS Library Preparation Kit, and XSEP MagBead.

Celemics Headlines

No Headlines